NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $994,000 | +24.9% | 16,300 | 0.0% | 0.11% | +31.0% |
| Q2 2018 | $796,000 | -65.5% | 16,300 | -24.9% | 0.09% | -68.2% |
| Q1 2018 | $2,306,000 | +5.5% | 21,700 | -40.7% | 0.27% | -4.5% |
| Q4 2017 | $2,186,000 | +119.0% | 36,600 | -12.0% | 0.29% | +82.8% |
| Q3 2017 | $998,000 | +22.8% | 41,600 | 0.0% | 0.16% | +12.1% |
| Q2 2017 | $813,000 | -16.7% | 41,600 | 0.0% | 0.14% | -31.4% |
| Q1 2017 | $976,000 | +70.6% | 41,600 | -10.7% | 0.20% | +53.4% |
| Q4 2016 | $572,000 | -28.6% | 46,600 | 0.0% | 0.13% | -26.5% |
| Q3 2016 | $801,000 | -6.2% | 46,600 | -22.3% | 0.18% | -13.0% |
| Q2 2016 | $854,000 | +3.5% | 60,000 | 0.0% | 0.21% | +5.6% |
| Q1 2016 | $825,000 | -18.4% | 60,000 | 0.0% | 0.20% | -16.2% |
| Q4 2015 | $1,011,000 | – | 60,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |